XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Geographic and Product Data
12 Months Ended
Dec. 30, 2011
Geographic and Product Data

Note 19 — Geographic and Product Data

 

The Company markets and sells its products in approximately 60 countries and has manufacturing sites in the United States, Switzerland and Japan. Other than the United States, Japan, Korea, China, and Spain the Company does not conduct business in any country in which its sales in that country exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s sales to unaffiliated customers is set forth below (in thousands):

 

Net sales to unaffiliated customers   2011     2010     2009  
United States   $ 13,852     $ 14,957     $ 16,088  
Japan     15,690       13,607       12,884  
Korea     8,142       6,082       5,366  
China     6,354       3,910       2,855  
Others*     18,727       16,402       13,867  
Total   $ 62,765     $ 54,958     $ 51,060  

 

*No other location individually exceeds 5% of total sales.

 

100% of the Company’s sales are generated from the ophthalmic surgical product segment and, therefore, the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are IOLs used in cataract surgery and ICLs used in refractive surgery.  The composition of the Company’s net sales by product line is as follows (in thousands):

 

Net sales by product line   2011     2010     2009  
ICLs   $ 32,072     $ 24,300     $ 21,046  
IOLs     27,547       27,550       26,299  
Other surgical products     3,146       3,108       3,715  
Total   $ 62,765     $ 54,958     $ 51,060  

 

The composition of the Company’s long-lived assets, consisting of property and equipment, between those in the United States, Switzerland, Japan and Australia is set forth below (in thousands):

 

Long-lived assets   2011     2010  
U.S   $ 1,460     $ 1,318  
Switzerland     1,010       967  
Japan     1,752       1,429  
Australia           18  
Total   $ 4,222     $ 3,732  

 

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.